Research Article
1 July 2007

Protein Arginine Methylation in Candida albicans: Role in Nuclear Transport

ABSTRACT

Protein arginine methylation plays a key role in numerous eukaryotic processes, such as protein transport and signal transduction. In Candida albicans, two candidate protein arginine methyltransferases (PRMTs) have been identified from the genome sequencing project. Based on sequence comparison, C. albicans candidate PRMTs display similarity to Saccharomyces cerevisiae Hmt1 and Rmt2. Here we demonstrate functional homology of Hmt1 between C. albicans and S. cerevisiae: CaHmt1 supports growth of S. cerevisiae strains that require Hmt1, and CaHmt1 methylates Npl3, a major Hmt1 substrate, in S. cerevisiae. In C. albicans strains lacking CaHmt1, asymmetric dimethylarginine and ω-monomethylarginine levels are significantly decreased, indicating that Hmt1 is the major C. albicans type I PRMT1. Given the known effects of type I PRMTs on nuclear transport of RNA-binding proteins, we tested whether Hmt1 affects nuclear transport of a putative Npl3 ortholog in C. albicans. CaNpl3 allows partial growth of S. cerevisiae npl3Δ strains, but its arginine-glycine-rich C terminus can fully substitute for that of ScNpl3 and also directs methylation-sensitive association with ScNpl3. Expression of green fluorescent protein-tagged CaNpl3 proteins in C. albicans strains with and without CaHmt1 provides evidence for CaHmt1 facilitating export of CaNpl3 in this fungus. We have also identified the C. albicans Rmt2, a type IV fungus- and plant-specific PRMT, by amino acid analysis of an rmt2Δ/rmt2Δ strain, as well as biochemical evidence for additional cryptic PRMTs.
Methylation of nitrogen atoms within arginine residues of proteins can influence a large number of cellular processes in eukaryotes, including protein transport, transcriptional activation, pre-mRNA splicing, and signaling pathways (5, 6). Effects of arginine methylation on intracellular transport can vary among eukaryotes: methylation facilitates nuclear export of several RNA-binding proteins in Saccharomyces cerevisiae (21, 37) but directs nuclear import of human RNA helicase A (40). Whereas the roles of arginine methylation are diverse, many roles are linked to modulation of protein-protein interactions (4, 5).
All eukaryotic organisms examined to date share one major protein arginine methyltransferase (PRMT) (5). Although this enzyme, termed Hmt1/Rmt1 in S. cerevisiae and PRMT1 in humans, has been shown to be the predominant PRMT in both of these organisms (18, 41), numerous other PRMTs have been identified. The human genome encodes at least nine PRMTs and different splice variants thereof (11); S. cerevisiae expresses three PRMTs, i.e., Hmt1, Hsl7, and Rmt2 (18, 24, 28, 29). Methyltransferase activity has been demonstrated for all three S. cerevisiae enzymes (18, 28, 29, 42), but their activities differ. Hmt1 is a type I PRMT, catalyzing the formation of ω-NG-monomethylarginine (ω-MMA) and asymmetric NG,NG-dimethylarginine (ADMA) (18). Hsl7 catalyzes formation of ω-MMA (28) and shows sequence similarity to mammalian PRMT5, which forms ω-MMA and symmetric NG,NG′-dimethylarginine (SDMA) (8). Rmt2 catalyzes the formation of δ-MMA, in which the internal δ nitrogen of arginine is methylated (29). Although the Rmt2 sequence is slightly similar to that of a mammalian small-molecule methyltransferase that targets guanidinoacetate (29), more closely related genes are found in fungal and plant genomes but are absent in animals.
S. cerevisiae shares different subsets of PRMT genes with other fungi, including Schizosaccharomyces pombe, Candida albicans, and Candida glabrata. S. pombe has a wide range of PRMT genes, including not only HMT1/RMT1, HSL7/RMT5, and RMT2 orthologs but also another type I methyltransferase gene, RMT3 (3, 31, 32, 48). Whereas C. glabrata, which is more closely related to S. cerevisiae than C. albicans (15), bears all three PRMT genes found in S. cerevisiae, the C. albicans genome sequencing project has revealed genes similar to HMT1 and RMT2 but no HSL7 ortholog (2, 43). In contrast to S. cerevisiae and S. pombe, Candida species are among the four most common pathogens to cause nosocomial bloodstream infections in the United States, with C. albicans causing the majority of these Candida infections (47). Therefore, understanding the molecular mechanisms at work in Candida and comparing them to mechanisms in other organisms may lend clinical insights. In addition to two PRMTs, C. albicans and S. cerevisiae share many genes that encode likely Hmt1 substrates due to the presence of arginine-glycine-(RG)-rich domains, including an ortholog of the major S. cerevisiae mRNA-binding protein Npl3.
In this study, we present the first identification of PRMTs in C. albicans and demonstrate functional homology of the HMT1 genes in this fungus and S. cerevisiae. Deletion of HMT1 and RMT2 from the C. albicans genome reveals roles of Hmt1 and Rmt2 in asymmetric dimethylation and δ-monomethylation of arginine, respectively. We also show data supporting the functional homology of the RG-rich domain of Npl3 between the two fungi. Lastly, given varying effects of arginine methylation on protein transport among eukaryotic systems, we have tested the effect of deletion of HMT1 on localization of C. albicans Npl3; these data support the hypothesis that Hmt1 facilitates nuclear export of Npl3 in C. albicans.

MATERIALS AND METHODS

Yeast strains, media, and growth conditions.

The yeast strains used in this study are listed in Table 1. Oligonucleotides used in plasmid and strain construction were synthesized at Integrated DNA Technologies, Inc., and are shown in Table 2. All S. cerevisiae strains were grown and genetic manipulations performed as previously described (26, 27, 34). C. albicans strains were grown in YPD medium or in synthetic dropout (SD) media lacking appropriate supplements to select for integrated markers (34); for Uri strains, YPD and SD media were supplemented with 80 μg/ml uridine. Generation times for C. albicans strains were determined by diluting overnight cultures to an optical density at 600 nm (OD600) of 0.1 in YPD and monitoring the OD600 every 30 min. For each strain, the log of normalized OD600 values was graphed as a function of time, and the linear part of the graph was used to calculate generation times.

Plasmid construction.

All plasmids used in this study are listed in Table 3. Plasmids expressing the C. albicans HMT1 and Homo sapiens PRMT1 genes under the control of S. cerevisiae HMT1 regulatory regions were constructed as follows. C. albicans HMT1 was amplified by PCR from CAI-1 genomic DNA (a gift of R. Wheeler) using oligonucleotides AM80 and AM81. H. sapiens PRMT1 was amplified from pPS1302 using oligonucleotides AM79 and AM82. PCR products were digested with NdeI and NsiI and inserted into NdeI-NsiI-digested pPS1872 to produce pAM160 (CaHMT1) and pAM161 (HsPRMT1), which express arginine methyltransferases with an additional MH dipeptide from S. cerevisiae Hmt1 at the C terminus.
The protein A (PrA)-ScHMT1 expression plasmid pAM91 was constructed by inserting an NdeI-MscI fragment from pPS1872 into NdeI-SmaI-digested pNOPPATA. The URA3 CaHMT1 plasmid pAM390 was constructed by inserting an XbaI-HindIII fragment from pAM160 into XbaI-HindIII-digested pRS316. The C. albicans HMT1 gene and surrounding regions were cloned by PCR amplification of BWP17 genomic DNA with oligonucleotides AM113 and AM114, XhoI and SpeI digestion, and insertion into XhoI-SpeI-digested pRS315, resulting in pAM322. The C. albicans HMT1 reconstitution plasmid (pAM385) resulted from the insertion of an XhoI-BsrBI fragment of pAM322 into XhoI-SmaI-digested pDS10 (30) followed by the elimination of an internal NcoI site by QuikChange mutagenesis (Stratagene) using oligonucleotides AM203 and AM204, resulting in a silent C-to-A mutation at the Ala196 codon.
The C. albicans NPL3 open reading frame (ORF), as defined in assembly 19 of the C. albicans genome sequence, was amplified from BWP17 genomic DNA with oligonucleotides AM143 and AM144, digested with NdeI and BamHI, and inserted into NdeI-BamHI-digested pNOPPATA to create the PrA-CaNPL3 plasmid pAM361. Homologous recombination in S. cerevisiae was used to create a gene fusion between the first three domains of S. cerevisiae NPL3 and the C. albicans NPL3 RGG domain. First, an ApaI site was introduced into the PrA-ScNPL3 plasmid pPS2389 through a silent G-to-C mutation in the Gly312 codon using QuikChange mutagenesis and oligonucleotides AM135 and AM136, resulting in pAM463. A PCR fragment containing the C. albicans NPL3 RGG domain flanked by sequences upstream and downstream of the S. cerevisiae NPL3 RGG domain was amplified using oligonucleotides AM141 and AM142. This fragment was cotransformed into FY23 with ApaI-linearized pAM463, and plasmids were rescued from cells that grew on medium lacking leucine. After transformation into Escherichia coli and purification, plasmids were sequenced at the University of Maine, Orono, DNA sequencing facility to verify proper fusion (ScNPL3 codons 1 to 278-CaNPL3 codons 231 to 336-CCC [proline codon]-ScNPL3 codons 404 to 414).

C. albicans strain construction.

A PCR-based homologous recombination strategy was used to create C. albicans strains lacking methyltransferase genes according to established protocols (45). PCR amplification of the HIS1 (from pGEM-HIS1) and ARG4 (from pRSARG4ΔSpeI) genes was performed with oligonucleotides AM145 and AM146 (HMT1) or AM147 and AM148 (RMT2). Sequential transformation of BWP17 with HIS1 and ARG4 PCR products to create homozygous deletion mutants was followed by reintroduction of the URA3 gene at its endogenous locus by transformation of PstI-NotI-digested pBSK-URA (30), resulting in AMC11 and AMC30, respectively. HMT1 was reintroduced into the hmt1Δ/hmt1Δ strain AMC35 by transformation of NcoI-linearized pAM385 and selection on medium lacking uridine. The URA3 marker was removed by selection on 5-fluoroorotic acid (5-FOA) and replaced at its endogenous locus as described above, to create AMC14. The RMT2 3′ sequences available in assembly 19 of the C. albicans genome sequence at the time of strain construction did not include the stop codon. To extend these sequences by inverse PCR, BWP17 genomic DNA was digested with TaqI, ligated, and digested with NsiI, and RMT2 3′ sequences were amplified using oligonucleotides AM117 and AM118. Sequencing with AM117 added 111 nucleotides to the assembly 19 RMT2 sequence but did not reveal the stop codon. Although RMT2 shows “complex sequence changes in assembly 20” due to the use of a different reference strain to fill in gaps (1), these 111 nucleotides are identical in our inverse PCR data, generated using BWP17 (a third-generation derivative of the original reference strain SC5314 [45]) and in those of assembly 20. Given these considerations, only the first 369 of 412 known codons were deleted from RMT2, and URA3, but not RMT2, was reintroduced into the rmt2Δ/rmt2Δ strain (AMC30). The heterozygous strain AMC28 serves as a positive control strain that should express Rmt2.
At each step, integration was tested by PCR using the following primer combinations: AM124/AM125 (HMT1), AM124/AM154 (hmt1Δ::HIS1), AM113/AM131 (hmt1Δ::ARG4), AM167/AM170 (RMT2), AM154/AM167 (rmt2Δ::HIS1), AM208/AM131 (rmt2Δ::ARG4), and AM213/AM214 (URA3). Final strains were also tested by Southern blotting: HMT1 alleles were detected by probing DraIII-digested genomic DNA with nucleotides −622 to +36 to the HMT1 ORF; RMT2 alleles were detected by probing HindIII/XbaI-digested genomic DNA with a 1-kb fragment PCR fragment generated from BWP17 genomic DNA using primers AM170 and AM199.
NPL3 was tagged with the green fluorescent protein (GFP) gene in HMT1/HMT1 and hmt1Δ/hmt1Δ C. albicans strains using established protocols (19). The GFP-URA3 cassette was amplified from pMG1602 with oligonucleotides AM173 and AM247 and products transformed into BWP17 and AMC36. Strains that grew on medium lacking uridine were tested for Npl3-GFP expression by anti-GFP immunoblotting and fluorescence microscopy. To introduce the S340A mutation and GFP tag into NPL3 simultaneously, oligonucleotides AM173 and AM244 were used to amplify the GFP-URA3 cassette from pMG1602 prior to transformation. The presence of the mutation and the sequence of the NPL3-GFP junction were confirmed by PCR amplification with oligonucleotides AM143 and AM258 and sequencing.

Protein expression and interaction studies.

Protein expression in S. cerevisiae and C. albicans was tested by lysing mid-log-phase cells with glass beads in radioimmunoprecipitation buffer supplemented with protease inhibitors, using a FastPrep cell disruptor (Bio101), followed by immunoblot analysis as described previously (27). CaNpl3-GFP methylation was tested by similarly lysing mid-log-phase cells in lysis buffer (150 mM KCl, 5 mM MgCl2, 20 mM Tris-HCl, pH 8.0) containing protease inhibitors and 0.2% Triton X-100. CaNpl3-GFP was precipitated from lysates (3 mg total protein) by incubation with anti-GFP (Roche; 5 μl) followed by incubation with protein G-agarose (Santa Cruz, sc-2002; 5 μl). After washing, CaNpl3-GFP was eluted by boiling in Laemmli buffer and analyzed by immunoblotting with anti-GFP and anti-ADMA (ASYM24; Upstate) antibodies.
PrA pulldown assays were performed essentially as described previously (26). Briefly, mid-log-phase cells expressing PrA fusion proteins were lysed in the lysis buffer described above with either 1% (Npl3) or 0.1% (Hmt1) Triton X-100. PrA fusion proteins and interacting proteins were precipitated with immunoglobulin G (IgG)-Sepharose (Pharmacia), washed, eluted with 3 M MgCl2, precipitated with trichloroacetic acid, and analyzed by immunoblotting.
For immunoblot analyses, antibodies were used at the following dilutions: polyclonal anti-ScNpl3, 1:5,000 (7); monoclonal 1E4 (anti-methyl-ScNpl3) (38, 46), 1:2,500; polyclonal anti-ScHmt1 (27), 1:2,000; polyclonal anti-myc, 1:2,000 (sc-789; Santa Cruz Biotechnology); monoclonal anti-GFP (Roche), 1:1,000; and secondary anti-mouse-horseradish peroxidase and anti-rabbit-horseradish peroxidase, 1:5,000 (Amersham). Polyclonal anti-Hmt1 and anti-myc antisera also detect PrA fusion proteins. All proteins were visualized by enhanced chemiluminescence (Amersham), and migration was compared to that of Benchmark standards (Invitrogen).

In vivo labeling with S-adenosyl-[methyl-3H]-l-methionine (3H-AdoMet).

C. albicans strains were grown at 30°C in YPD medium as previously described by Porras-Yakushi et al. (33), with the following changes. The strains were harvested by centrifugation at 1,000 × g for 3 min at 4°C, and the pellets were washed a total of three times by the addition of 1 ml of sterile water followed by centrifugation for 5 min at 10,600 × g at room temperature.
Fractionation by sodium dodecyl sulfate (SDS) gel electrophoresis was carried out as previously described (33). For fluorography, the gels were treated with En3Hance (Perkin-Elmer Life Sciences) for 1 h and then washed for 20 min in water. Gels were dried in vacuo for a total of 3 h (2 h at 70°C and 1 h at room temperature).

Amino acid analysis.

Analysis was performed as previously described by Niewmierzycka and Clarke (29) with the following modifications. After precipitation with trichloroacetic acid, lysates were centrifuged at 1,000 × g for 20 min at 25°C. The pellets were washed once with 50 μl of cold acetone, centrifuged at 1,000 × g for 20 min at 25°C, and allowed to dry prior to being acid hydrolyzed. Hydrolysates were mixed with nonradiolabeled standards (50 μl of 2 mM SDMA and 5 μl each of 0.2 M ADMA and 0.2 M ω-MMA [Sigma Chemical Co., St. Louis, MO]) prior to being loaded on a Beckman AA-15 sulfonated polystyrene cation-exchange column (29).

Fluorescence microscopy.

Cells expressing GFP-tagged CaNpl3 proteins were grown to mid-log phase in synthetic dropout medium lacking uridine, washed with phosphate-buffered saline (PBS), and incubated with 10 μg/ml DAPI (4′,6′-diamidino-2-phenylindole) in PBS for 30 min to visualize nuclei. Cells were washed with PBS and visualized by fluorescence microscopy (Olympus BX51; GFP and DAPI filters). Images were captured with an EvolutionVF color digital camera (noncooled, 12-bit; MediaCybernetics) and QCapture Pro 5.0 software. For each filter, exposure times were equivalent for all strains.

RESULTS

Functional conservation of HMT1.

A BLAST search of nonredundant databases with the major type I arginine methyltransferase from S. cerevisiae reveals a clear C. albicans ortholog. These proteins not only are very similar among numerous fungal species (Fig. 1A and data not shown), but also share a high degree of similarity with the predominant human PRMT, PRMT1 (Fig. 1A) (35, 41). To test whether PRMT function is conserved between these two fungal species, C. albicans HMT1 (CaHMT1) was subcloned into a plasmid under the control of the endogenous S. cerevisiae HMT1 (ScHMT1) promoter (official gene names consist of three letters and a number, and therefore the Ca and Sc prefixes are used to distinguish orthologous genes from the two organisms). Although HMT1 is not an essential gene in S. cerevisiae, Hmt1 is required in a strain that contains a point mutation in one of its substrates, the major mRNA-binding protein Npl3 (npl3-1) (24), or that lacks the 80-kDa mRNA cap-binding protein Cbp80 (cbp80Δ) (37). Plasmids that express S. cerevisiae, C. albicans, and human PRMTs were transformed into these S. cerevisiae strains. Cells expressing CaHmt1 grow as robustly as cells expressing ScHmt1 (Fig. 1B). Thus, C. albicans Hmt1 supports all essential Hmt1 functions in these S. cerevisiae strains. In contrast, expression of human PRMT1 allowed partial growth in the absence of Cbp80 but did not support growth of the npl3-1 strain (Fig. 1B).
To test methyltransferase activity, these PRMT expression plasmids were transformed into S. cerevisiae cells lacking endogenous HMT1 (hmt1Δ), and levels of Hmt1, Npl3, and methylated Npl3 were determined by immunoblotting (Fig. 1C). The antiserum raised against ScHmt1 (27) also recognizes CaHmt1, which migrates slightly faster, but not human PRMT1 (Fig. 1C, top panel); relative expression levels of the three PRMTs cannot be determined due to epitope differences, but all three PRMTs are expressed from the ScHMT1 promoter. Although Npl3 levels are similar in all strains (Fig. 1C, middle panel), levels of methylated Npl3 vary depending on which methyltransferase is expressed. CaHmt1 methylates S. cerevisiae Npl3 almost as well as ScHmt1, whereas Npl3 methylation by the human enzyme is significantly reduced in comparison (Fig. 1C, bottom panel). Thus, C. albicans Hmt1 demonstrates significant methyltransferase activity for a known Hmt1 substrate in S. cerevisiae.
The crystal structures of S. cerevisiae Hmt1 and human PRMT1 reveal PRMT dimerization, which is important for enzyme function (44, 51). To determine whether C. albicans Hmt1 showed similar protein-protein interactions, heterodimerization of CaHmt1 and ScHmt1 proteins was tested. CaHmt1 was coexpressed with a PrA-tagged form of ScHmt1 in hmt1Δ S. cerevisiae cells. After PrA-ScHmt1 isolation, untagged Hmt1 proteins associated with PrA-ScHmt1 were detected by immunoblotting (Fig. 1D). Both ScHmt1 and CaHmt1 copurify with PrA-ScHmt1, supporting cross-species Hmt1 hetereodimerization (lane 3, top panel) as well as homodimerization of ScHmt1 (lane 2). The presence of a ∼40-kDa copurifying protein depends on the presence of untagged Hmt1 (lanes 1 and 2), the presence of the Hmt1 dimerization domain (lanes 2 and 4) (44) and the expression of PrA-ScHmt1 (lanes 2 and 5). The lower band in the C. albicans lane is unlikely to represent a degradation product of PrA-ScHmt1, since the protein in this lane migrates slightly faster than the minor band seen in the absence of untagged Hmt1 expression (lane 1). The ability of C. albicans Hmt1 to bind to S. cerevisiae Hmt1, combined with the conservation of regions involved in ScHmt1 dimerization (Fig. 1A) suggests that the C. albicans enzyme may dimerize in vivo.

Hmt1, the major PRMT in C. albicans.

To determine whether HMT1 and RMT2 genes encode functional PRMTs in C. albicans, strains with homozygous deletions of each gene were created by homologous recombination. The entire HMT1 gene was removed in hmt1Δ/hmt1Δ strains, and over 89% of RMT2 was removed in rmt2Δ/rmt2Δ strains, including all methionine codons and the entire AdoMet-binding motif. Immunoblotting with the antibody raised against ScHmt1 revealed the presence of a ∼39-kDa protein in the reconstituted strain that was absent in hmt1Δ/hmt1Δ cells (Fig. 2A). All hmt1Δ/hmt1Δ and rmt2Δ/rmt2Δ strains grew as robustly as reconstituted or heterozygous strains in rich media. The generation times of two hmt1Δ/hmt1Δ strains were 1.35 ± 0.08 h and 1.36 ± 0.02 h, compared to 1.36 ± 0.07 h and 1.32 ± 0.05 h for two reconstituted hmt1Δ/hmt1Δ+HMT1 strains. Generation times of two rmt2Δ/rmt2Δ strains were 1.37 ± 0.09 h and 1.34 ± 0.06 h, compared to 1.32 ± 0.07 h for the rmt2Δ/RMT2 heterozygous strain. Therefore, similar to the case for the S. cerevisiae orthologs (18, 24, 29), neither HMT1 nor RMT2 is essential for C. albicans growth.
To test PRMT activity in vivo, C. albicans cells with and without each methyltransferase were grown in the presence of 3H-AdoMet. Radiolabeled proteins were analyzed by SDS-polyacrylamide gel electrophoresis and fluorography and acid hydrolyzed for amino acid analysis to identify methylarginine species. Radioactive labeling of multiple proteins was lower in lysates of hmt1Δ/hmt1 cells than in those of hmt1Δ/hmt1Δ+HMT1 cells (Fig. 2B, right panel), suggesting lower levels of arginine methylation of these substrates in the absence of Hmt1. The radioactive ADMA peak visible in acid hydrolysates of proteins from the hmt1Δ/hmt1Δ+HMT1 strain (Fig. 2C, upper panel) is absent in hmt1Δ/hmt1Δ acid hydrolysates; the ω-MMA peak is also significantly reduced in hmt1Δ/hmt1Δ cells (Fig. 2C, lower panel). These results indicate that, as in S. cerevisiae (18), Hmt1 is the major type I arginine methyltransferase in C. albicans.
In contrast, levels of radioactively labeled proteins are similar in rmt2Δ/RMT2 and rmt2Δ/rmt2Δ cells (Fig. 3A, right panel). This result is consistent with the presence of only one known Rmt2 substrate in S. cerevisiae: Rmt2 monomethylates ribosomal protein L12 (Rpl12) in S. cerevisiae at a single site (10), and CaRpl12 may comigrate with strongly labeled proteins between the 14.4- and 21.5-kDa markers. In amino acid analysis chromatography, δ-MMA migrates similarly to SDMA (29), and, as predicted, a small peak that elutes close to the SDMA standard in the rmt2Δ/RMT2 and HMT1 samples is reduced in rmt2Δ/rmt2Δ hydrolysates (Fig. 3B). These results are consistent with Rmt2 catalyzing δ-MMA formation in C. albicans. The presence of a small amount of radioactivity in the δ-MMA position suggests that an additional methyltransferase activity may be present that forms symmetric dimethylarginine residues, although no gene that may encode this activity has been identified.

Identification of a C. albicans Npl3 ortholog.

The first cellular function demonstrated for arginine methylation in vivo was a role in nuclear export of two Hmt1 substrates in S. cerevisiae, including the mRNA-binding protein Npl3 (37). Subsequent studies demonstrated that methylation facilitates nuclear import of human RNA helicase A (40) and that PRMT1 deletion increased cytoplasmic localization of mammalian RNA-binding protein Sam68 (12), also suggesting a role for methylation in import. We therefore wished to test whether arginine methylation has a role in either nuclear export or import of methylated RNA-binding proteins in C. albicans. A putative Npl3 ortholog was identified in the C. albicans genome (Fig. 4A). Npl3 is not as highly conserved between fungal species as is Hmt1, but S. cerevisiae Npl3 and its C. albicans ortholog both contain two RNA recognition motifs and a C-terminal domain with many arginine-glycine-glycine (RGG) tripeptides that are extensively methylated by Hmt1 in S. cerevisiae (26). The two proteins also share a heptapeptide at the C terminus that includes a serine targeted by the SR protein kinase in S. cerevisiae, Sky1 (20, 50).
To test whether Npl3 was functionally conserved between fungal species, we subcloned full-length C. albicans NPL3 (CaNPL3) into an S. cerevisiae PrA expression vector. A second plasmid expresses a PrA-tagged chimeric protein containing the first three domains of ScNpl3, the RGG domain of CaNpl3, and the last 11 amino acids of ScNpl3. These plasmids and control plasmids were transformed into npl3Δ S. cerevisiae cells bearing a URA3 plasmid for ScNpl3 expression. After growth on 5-FOA medium, cells expressing the chimeric protein grew as well as those expressing ScNpl3, but cells expressing full-length CaNpl3 grew only slightly better than cells bearing the expression vector (Fig. 4B). Therefore, although all proteins are expressed at similar levels (Fig. 4C), the RGG domain of CaNpl3 can replace essential functions of the ScNpl3 RGG domain, but the full-length C. albicans protein cannot perform functions essential for growth of the npl3Δ cells.
Methylation of ScNpl3 disrupts protein-protein interactions, including Npl3 self-association (49). The RGG domain helps direct ScNpl3 self-association, since PrA-ScNpl3 can interact with the RGG domain alone in hmt1Δ cells (A. McBride, unpublished data). Therefore, we tested whether the CaNpl3 RGG domain could mediate methylation-sensitive Npl3-Npl3 interaction in S. cerevisiae (Fig. 4C). The PrA-Npl3 plasmids were transformed into Δhmt1 and HMT1 cells expressing myc-tagged ScNpl3 and PrA-Npl3, and associated proteins were isolated with IgG-Sepharose. Whereas the chimeric Npl3 showed slightly less interaction than ScNpl3 with ScNpl3-myc, binding of full-length CaNpl3 to ScNpl3-myc was severely reduced, suggesting that domains other than the RGG domain influence ScNpl3 self-association. In all cases, however, Npl3-Npl3 binding is decreased in the presence of HMT1 (Fig. 4C).

Methylation and nucleocytoplasmic transport of Npl3 in C. albicans.

The methylation sensitivity of Npl3 dimerization in S. cerevisiae has been linked to the role of arginine methylation in ScNpl3 export (26). Given the increased interaction of Npl3 with proteins containing the CaNpl3 RGG domain in hmt1Δ S. cerevisiae cells, we tested whether Npl3 is methylated in C. albicans and whether Hmt1 influences its nuclear transport. To detect Npl3 methylation in C. albicans, a GFP tag was inserted at the C terminus of one of the endogenous NPL3 alleles. Npl3-GFP immunoprecipitated from cells with or without Hmt1 was detected with anti-GFP antibodies to detect relative protein levels and with an antidimethylarginine antiserum to determine relative methylation levels (Fig. 5A). The methylation-specific antiserum only detected Npl3-GFP proteins in cells expressing HMT1. Immunoprecipitates from cells lacking the GFP tag or expressing the GFP tag alone do not contain any proteins recognized by the dimethylarginine antiserum. Therefore, Npl3 is an Hmt1 substrate in C. albicans.
Fluorescence microscopy revealed that wild-type Npl3-GFP colocalizes with DAPI staining and is therefore nuclear in C. albicans in the presence or absence of Hmt1 (Fig. 5B). Although this result indicates that Hmt1 is unlikely to have a role in expediting nuclear import, inhibitory effects of HMT1 deletion on nuclear export cannot be determined in these cells. In S. cerevisiae, nuclear export defects have been probed using a temperature-sensitive nucleoporin mutation that slows Npl3 import (25, 37). The diploidy of C. albicans and paucity of selectable markers led us to devise another strategy to slow Npl3 nuclear import to test the effect of Hmt1 on Npl3 export in C. albicans. An S-to-A mutation in the serine that is phosphorylated by Sky1 decreases Npl3 import in S. cerevisiae (20, 50). The amino acids surrounding this serine in the C terminus of Npl3 are conserved in C. albicans (Fig. 4A), which also contains orthologs of Sky1 and Mtr10, the Npl3 import receptor (2, 36). Hmt1 methylates npl3-S340A in C. albicans (Fig. 5A), and npl3-S340A localizes throughout HMT1 cells at steady state (Fig. 5B), indicating that the rate of Npl3 import relative to export is decreased by this mutation. When this mutation was introduced into hmt1Δ/hmt1Δ cells, however, npl3-SA-GFP showed nuclear localization similar to that of wild-type Npl3-GFP (Fig. 5b). This result demonstrates that Hmt1 deletion lowers the rate of npl3-SA-GFP export relative to that of import, suggesting that Hmt1 facilitates nuclear export of Npl3 in C. albicans.

DISCUSSION

Sequencing of the C. albicans genome has revealed an intriguing complement of PRMT genes. This species contains a clear ortholog of the ubiquitous type I methyltransferase Hmt1 as well as a type IV arginine methyltransferase, Rmt2, but it lacks a clear type II Hsl7/PRMT5 ortholog. Given the presence of type II enzymes in many other eukaryotes and the apparent specificity of type IV enzymes to fungal and plant species, C. albicans offers a particularly interesting system in which to explore roles of these eukaryotic enzymes.
Although type I PRMT sequences are highly conserved among eukaryotes, the in vivo comparison of S. cerevisiae, C. albicans, and human type I PRMTs demonstrates functional differences that correlate with sequence similarity (Fig. 1). CaHmt1 supports growth of S. cerevisiae strains that require Hmt1, whereas human PRMT1 supports partial growth of a cbp80Δ strain but does not allow growth of an npl3-1 strain. In these experiments all PRMTs were expressed from the ScHmt1 promoter to normalize transcription levels. Therefore, although PRMT1 protein levels are not known, this result agrees with the finding that overexpression of this PRMT1 isoform is required for growth of an hmt1Δ npl3-1 strain (35). Similarly, the two fungal PRMTs methylated Npl3 to a greater extent than did human PRMT1. The ability of fungal Hmt1 proteins to heterodimerize, combined with the similarity in their antenna sequences and in the region of the AdoMet-binding domain sequences to which the antenna binds, suggests that CaHmt1 is also likely to dimerize in vivo.
Amino acid analysis of radiolabeled proteins in hmt1Δ/hmt1Δ and rmt2Δ/rmt2Δ C. albicans cells reveals that both Hmt1 and Rmt2 function as arginine methyltransferases in this fungus. The radiolabeling of a number of proteins decreases in hmt1Δ/hmt1Δ cells, and the decrease in the ADMA and MMA peaks confirms that CaHmt1 is a type I methyltransferase. The residual labeled proteins in hmt1Δ/hmt1 cells may indicate other types of protein methylation, such as lysine methylation, or potentially conversion of tritiated AdoMet to methionine and translational incorporation. No decrease is seen in overall protein methylation in rmt2Δ/rmt2Δ cells; this result is consistent with only one Rmt2 substrate, ribosomal protein L12, being identified in S. cerevisiae (10). The decrease in a peak that migrates close to the SDMA standard, however, supports the identification of CaRmt2 as a type IV methyltransferase.
Interestingly, enlargement of the region around the SDMA standard in the rmt2Δ/rmt2Δ sample reveals a small residual peak (Fig. 3B). No such peak was seen in rmt2Δ S. cerevisiae hydrolysates (29). In addition, there is a small residual peak in the ω-MMA region of the hmt1Δ/hmt1Δ sample (Fig. 2C). C. albicans may, therefore, express one or more PRMTs that are not identified through BLAST searches; such an enzyme might be a type II PRMT, which would catalyze SDMA and ω-MMA region formation. The anti-ScHmt1 antiserum recognizes two proteins larger than CaHmt1 in hmt1Δ/hmt1Δ cells (Fig. 2A). Although it is intriguing to consider whether one of these proteins might be another C. albicans PRMT, neither represents Rmt2, since both proteins are detected in rmt2Δ/rmt2Δ lysates (A. McBride, unpublished data). Human PRMT1 is more similar to fungal Hmt1 proteins than to the human type II enzyme PRMT5 (17), yet PRMT1 is not recognized by the antiserum (Fig. 1b). Therefore, neither of the higher-molecular-weight proteins recognized by the anti-ScHmt1 antiserum is likely to be a type II PRMT. The putative enzyme or enzymes responsible for residual peaks in C. albicans hmt1Δ/hmt1Δ and rmt2Δ/rmt2Δ cells therefore remain to be identified.
To address the in vivo function of C. albicans Hmt1, we developed an assay to monitor nuclear export of the putative C. albicans Npl3 ortholog, a likely Hmt1 substrate. In S. cerevisiae, Npl3 shuttles between the nucleus and the cytoplasm but is predominantly nuclear at steady state (7, 16). Sky1 phosphorylation of ScNpl3 influences its binding to mRNA and import factor Mtr10, and deletion of Sky1 or mutation of its target site in ScNpl3 slows Npl3 nuclear import (20, 50). In our assay, an S-to-A point mutation at the putative phosphorylation site was used to slow import of CaNpl3-GFP, allowing detection of Npl3 export defects in hmt1Δ/hmt1Δ cells. Unlike the S. cerevisiae nuclear export assay (25), this assay detects steady-state localization and does not allow repression of Npl3-GFP synthesis before import is inhibited; therefore, we cannot rule out that Hmt1 may possibly slow Npl3 import rather than facilitate export. Regardless of the mechanism, methylation of CaNpl3 clearly favors export of this shuttling RNA-binding protein, in contrast to the role of methylation in expediting import of mammalian RNA-binding proteins RNA helicase A and Sam68 (12, 40).
The presence of eight RS/SR dipeptides in the C terminus of S. cerevisiae Npl3, including six within the RGG domain, has led to comparisons with mammalian SR proteins (38, 50), particularly because the yeast SR protein kinase Sky1 targets the final RS dipeptide. Only this final RS dipeptide, which is found in the context of a conserved heptapeptide, is found in the C. albicans Npl3 protein (Fig. 4A). Five other fungal species also encode Npl3-like proteins with RNA recognition motifs, RGG domains, and similar C-terminal heptapeptides with the consensus sequence R(E/D)RSP(T/V)R (Candida glabrata, ORF CAGL0H04763g; Debaryomyces hansenii, ORF DEHA0D05115g; and Kluyveromyces lactis, ORF KLLA0B00979g [14] and Ashbya gossypii, ORF ADR183Cp [13]). Within the RGG domains of these five proteins, only a single SR is found, in the RGG domain of the Ashbya gossypii Npl3-like protein. These comparisons, combined with the ability of the chimeric ScNpl3 protein bearing the CaNpl3 RGG domain to support wild-type growth of S. cerevisiae lacking Npl3, suggest that this family of likely RNA-binding proteins does not require RS/SR dipeptides within the RGG domain for function.
The C. albicans genome encodes a number of likely Hmt1 substrates in addition to Npl3. Although some of these proteins with RG-rich domains are orthologous to known targets for methylation in S. cerevisiae, other RGG-containing proteins in one species share sequences with proteins that lack RGG domains in the other fungus. The hmt1Δ/hmt1Δ C. albicans strains described in this study will allow the exploration of these differences, including testing whether arginine methylation affects the function of these proteins. In addition, the presence of residual methylarginine peaks in protein hydrolysates of hmt1Δ/hmt1Δ and rmt2Δ/rmt2Δ C. albicans suggests that future work may uncover another PRMT in this pathogenic fungus.

ADDENDUM IN PROOF

The Npl3 protein as defined in assembly 20 of the C. albicans sequencing project (Fig. 4A) contains 58 more N-terminal amino acids than the assembly 19 Npl3 used in the experiments shown in Fig. 4B and C.
FIG. 1.
FIG. 1. Hmt1 is functionally conserved between S. cerevisiae and C. albicans. (A) Clustal W alignment (9) of type I arginine methyltransferase proteins Saccharomyces cerevisiae Hmt1 (S. cer.), Candida albicans Hmt1 (C. alb.), and human PRMT1 (H. sap.) HRMT1L2v.1 (35). Indicated motifs include conserved methyltransferase motifs (I, post-I, II, and III) that mediate binding to the enzyme cofactor AdoMet, double-E (bold) and THW loop motifs common to protein methyltransferases, and the “antenna” domain (positions 175 to 204) that mediates dimerization of S. cerevisiae Hmt1 through hydrophobic interactions with the AdoMet-binding domain (dashed boxes) (44). Asterisks denote identical residues in all sequences, colons denote conserved substitutions, and periods denote semiconserved substitutions. (B) S. cerevisiae strains that require HMT1 due to the presence of the npl3-1 mutation (PSY866) or deletion of the 80-kDa cap-binding protein gene (PSY1191) were transformed with CEN LEU2 plasmids that express either no Hmt1 (vector, pRS315) or one of the arginine methyltransferases shown in panel A (Sc, S. cerevisiae Hmt1, pPS1872; Ca, C. albicans Hmt1, pAM160; Hs, H. sapiens PRMT1, pAM161). The functionality of each methyltransferase was tested by incubation on medium containing 5-FOA, which selects for loss of a URA3 ScHMT1 expression plasmid, at 25°C (hmt1Δ npl3-1) or 30°C (hmt1Δ cbp80Δ) for 3 days. (C). An hmt1Δ S. cerevisiae strain (PSY865) was transformed with the plasmids described for panel B, and grown at 30°C to mid-log phase, and lysed in radioimmunoprecipitation assay buffer. Total protein (5 μg) was analyzed by immunoblotting with polyclonal antisera raised against ScHmt1 (27) and ScNpl3 (7) from S. cerevisiae and a monoclonal antibody that specifically recognizes methylated ScNpl3 (1E4) (38, 46). (D) A PrA fusion to S. cerevisiae Hmt1 (+) was expressed from pAM91 in cells expressing untagged ScHmt1 (Sc; pPS1307), CaHmt1 (Ca; pAM390), or ScHmt1 lacking the antenna domain (Scm; pPS2575). CaHmt1 was also expressed in the presence of the PrA vector (−; pNOPPATA). Proteins from mid-log-phase cells were precipitated with IgG-Sepharose. Proteins isolated from 0.5 mg lysate (beads) and 10 μg lysates were analyzed by immunoblotting with anti-ScHmt1 antiserum, which also binds to PrA.
FIG. 2.
FIG. 2. C. albicans Hmt1 is not essential and is the major PRMT. (A) hmt1Δ/hmt1Δ (AMC11; HMT1−) and hmt1Δ/hmt1Δ+HMT1 (AMC14; HMT1+) C. albicans strains were created using a PCR-based strategy. Total protein (10 μg) from these strains was analyzed by immunoblotting with anti-ScHmt1 antiserum. (B) C. albicans strains were labeled in vivo with [3H]AdoMet as described in Materials and Methods. Proteins in cell extracts (50 μg) were resolved by SDS gel electrophoresis and analyzed by Coomassie blue staining and fluorography. The dried gel was exposed to Kodak X-Omat AR film at −80°C for 10 days to detect methylated proteins. Arrows indicate major 3H-methylated polypeptides found in the hmt1Δ/hmt1Δ+HMT1 strain (AMC14; HMT1+) expressing the methyltransferase and absent or greatly reduced in the mutant hmt1Δ/hmt1Δ strain (AMC11; HMT1−). (C) Amino acid analysis of C. albicans proteins from lysed cells in vivo labeled with [3H]AdoMet. Acid-hydrolyzed proteins (150 μg) were fractionated on a cation-exchange column as described in Materials and Methods. Radioactivity (3H) (solid line) was determined by scintillation counting. Nonradiolabeled amino acid standards of ADMA, ω-MMA, and SDMA were added to the hydrolysate and detected using a ninhydrin assay (dashed line). The upper panel shows the labeling in cells expressing Hmt1 (AMC14; HMT1+), and the lower panel shows the labeling in cells lacking Hmt1 (AMC11; HMT1−). The radioactivity in the off-scale fractions of the upper panel is 2,625 for fraction 72, 5,707 for fraction 73, and 1,172 for fraction 87. In these experiments, the 3H-labeled methylated derivatives eluted slightly earlier than the nonisotopically labeled standards due to an isotope effect (18).
FIG. 3.
FIG. 3. C. albicans Rmt2 catalyzes the formation of δ-MMA as a minor PRMT. (A) C. albicans strains RMT2/rmt2Δ (AMC28; RMT2+) and rmt2Δ/rmt2Δ (AMC30; RMT2−) were labeled in vivo with [3H]AdoMet as described in Materials and Methods. Proteins in cell extracts (50 μg) were analyzed by SDS gel electrophoresis as described in the legend to Fig. 2. The dried gel was exposed to Kodak BioMax MS film at −80°C for 10 days. (B) Amino acid analysis of C. albicans proteins from lysed RMT2/rmt2Δ and rmt2Δ/rmt2Δ cells labeled in vivo with [3H]AdoMet as described in the legend Fig. 2. The upper panel shows the labeling in cells expressing Rmt2 (AMC28; RMT2+), and the lower panel shows the labeling in rmt2Δ/rmt2Δ cells (AMC30; RMT2−). The arrow indicates the peak that decreases in the absence of Rmt2. The radioactivity in the off-scale fractions for the upper panel is 2,062 for fraction 73, 2,759 for fraction 74, and 1,079 for fraction 75; for the lower panel it is 1,973 for fraction 73 and 1,411 for fraction 74. The radioactive derivatives are expected to elute slightly earlier than the standards, as described in the Fig. 2 legend.
FIG. 4.
FIG. 4. The RGG domain of C. albicans Npl3, but not full-length protein, can function in S. cerevisiae. (A) Clustal W alignment (9) of S. cerevisiae RNA-binding protein Npl3 (S. cer.) and the C. albicans Npl3 ortholog (C. alb.). RNA recognition motifs (RRMs) and arginine-glycine-rich (RGG) domains are shown. Sky1-mediated phosphorylation of serine 411 (bold) in the conserved C-terminal heptapeptide facilitates Npl3 nuclear import in S. cerevisiae (20, 50). SR dipeptides found in S. cerevisiae, but not C. albicans, Npl3 are underlined. Asterisks denote identical residues in all sequences, colons denote conserved substitutions, and periods denote semiconserved substitutions. (B) An S. cerevisiae strain lacking NPL3 (PSY814) was transformed with plasmids that express PrA alone (vector; pNOPPATA) or PrA fused to S. cerevisiae Npl3 (ScNpl3; pPS2389), C. albicans Npl3 (CaNpl3; pAM361), or a chimeric protein composed of the first three domains of ScNpl3 with the RGG domain of CaNpl3 (ScNpl3-CaRGG; pAM362). Cells were grown overnight to mid-log phase in medium lacking leucine and washed, and 10-fold dilutions (106 to 103 cells) were plated on 5-FOA medium and grown at 30°C for 2 days. (C) hmt1Δ (YAM533) and HMT1 (YAM535) S. cerevisiae strains expressing myc-tagged ScNpl3 were transformed with the PrA-Npl3 plasmids shown in panel B. Proteins from mid-log-phase cells were precipitated with IgG-Sepharose. Proteins isolated from 1.7 mg lysate (beads) and total lysates (20 μg) were analyzed by immunoblotting with a polyclonal anti-myc antiserum, which also binds to PrA.
FIG. 5.
FIG. 5. Hmt1 influences nucleocytoplasmic transport of C. albicans Npl3. (A) NPL3 was GFP tagged by homologous recombination in homozygous C. albicans strains with (+; AMC46 and AMC47) or without (−; AMC48 and AMC49) Hmt1. PCR products used for recombination contained either wild-type NPL3 sequences (WT) or introduced a T-to-G mutation in codon 340, encoding an S-to-A (SA) mutation in the C terminus of Npl3. Equal amounts of total protein from mid-log-phase GFP-tagged and parental cells were immunoprecipitated with anti-GFP and PrG-Sepharose. Equal amounts of each precipitate were analyzed by immunoblotting with anti-GFP (from 0.3 mg total protein) and antidimethylarginine antiserum (from 0.6 mg total protein). Parental strains lacking GFP (−; BWP17 [+Hmt1] and AMC36 [−Hmt1]) and an HMT1/HMT1 strain expressing GFP alone (G; MLR62) were used as controls. (B) HMT1/HMT1 (HMT1+; AMC46, AMC47) and hmt1Δ/hmt1Δ (HMT1−; AMC48 and AMC49) strains were grown to mid-log phase and stained with DAPI. Cells were visualized by Nomarski and fluorescence microscopy using GFP and DAPI filters. For each filter, exposure times were equivalent for all strains.
TABLE 1.
TABLE 1. Strains used in this study
Species and strainGenotypeSource or reference
S. cerevisiae  
    FY23MAT a ura3-52 trp1Δ63 leu2Δ1 GAL+F. Winston
    PSY865MATα hmt1Δ::HIS3 ade2 ade8 ura3 leu2 his3 lys124
    PSY866MAT a ade2 ade8 ura3 leu2 his3 lys1 Δhmt1::HIS3 npl3-1 + pPS130724
    PSY814MATα npl3Δ::HIS3 ade2 ade8 can1 ura3 leu2 his3 lys1 trp1 + YCp50-NPL3-323
    PSY1191MAT a ade2 ade8 ura3 leu2 his3 Δhmt1::HIS3 Δcbp80::HIS3 + pPS130737
    YAM533MATα hmt1Δ::HIS3 NPL3-myc::URA3 ade2 ade8 ura3 leu2 his3 lys126
    YAM535MAT a NPL3-myc::URA3 ade2 ade8 ura3 leu2 his3 lys126
C. albicans  
    AMC11 hmt1Δ::HIS1 ura3Δ::λimm434::URA3-IRO1 arg4::hisG his1::hisGThis study
 hmt1Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC14 hmt1Δ::HIS1 ura3Δ::λimm434::URA3-IRO1 arg4::hisG his1::hisGThis study
 hmt1Δ::ARG4::HMT1 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC28 rmt2Δ::HIS1 ura3Δ::λimm434::URA3-IRO1 arg4::hisG his1::hisGThis study
 RMT2 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC30 rmt2Δ::HIS1 ura3Δ::λimm434::URA3-IRO1 arg4::hisG his1::hisGThis study
 rmt2Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC35 hmt1Δ::HIS1 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 hmt1Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC36 hmt1Δ::HIS1 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 hmt1Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
    AMC46 NPL3-GFP::URA3 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 NPL3 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC47 npl3-SA-GFP::URA3 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 NPL3 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC48 NPL3-GFP::URA3 hmt1Δ::HIS1 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 NPL3 hmt1Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisG 
    AMC49 npl3-SA-GFP::URA3 hmt1Δ::HIS1 ura3Δ::λimm434 arg4::hisG his1::hisGThis study
 NPL3 hmt1Δ::ARG4 ura3Δ::λimm434 arg4::hisG his1::hisG 
    BWP17 ura3Δ::λimm434 arg4::hisG his1::hisG45
 ura3Δ::λimm434 arg4::hisG his1::hisG 
    MLR62 ura3Δ::λimm434 ARG4::URA3::arg4::hisG his1::hisG::pTEF1-GFPA. Mitchell
 ura3Δ::λimm434 arg4::hisG his1::hisG 
TABLE 2.
TABLE 2. Oligonucleotides used in this study
OligonucleotideSequence (5′→3′)aSite/mutationb
AM79cccatgcatGCGCATCCGGTAGTCGGTGGAGCNsiI+
AM80ccccatATGTCTGAATCAGCTACTGATAAATCACNdeI+
AM81cccatgcatGCGTAAAAAGTAAGTGTATCCACCCNsiI+
AM82GGCcatATGGAAGTGTCCTGTGGCCAGGCGGNdeI+
AM113cccactagtCCCTTCATTCCGTAATTTCTGTGSpeI+
AM114cccctcgagCAGCTCCAGGGAGGGCTTCGXhoI+
AM117GGTGCATCAGGTGCATCATCAATAACGAC 
AM118GTGATACCATAACCAGCTCAGCCAGCTC 
AM124CCCAAACAAGATGTCTGAATCAGC 
AM125GTTCTGGTGATAAAATAGCTCTCC 
AM131GCTCTTGGTGGTACTGCTAAAAGTGCCG 
AM135GAGGCGGCTTCGGTGGGcCCAGAGGTGGATTTGGApaI+
AM136CCAAATCCACCTCTGGgCCCACCGAAGCCGCCTCApaI+
AM141CAGAGGTTCTGTCATTACTGTTGAAAGAGATGACAATCCTccaccaccaagaggtagaggaggtttcagaggtag 
AM142GGCTTACCTGGTTGGTGATCTTTCACGTGGAGCATCTCTgggatcgtatgatccacctctgtcgttg 
AM143ccccatATGGATGGTCCAGTTGAAGTTACTAAACAGNdeI+
AM144cccggaTCCATAGTACATTCCACTTCTATCTTCTCCGBamHI+
AM145CCAATATAGATTATATCCCAAACAAGATGTCTGAATCAGCTACTGATAAATCACAATTGTC gttttcccagtcacgacgtt 
AM146GGCTTTGGGGAGAAATATAATAGGGATATACCAGTCTACACATTACGAACACCAATACTA GCtgtggaattgtgagcggata 
AM147CCATATATCAACTCCTTCCCATTTTCCTTCTTATCTTTCCACCCCCACACACCCCTTATCAAT gttttcccagtcacgacgtt 
AM148CTTCATAAATTATTTGTCTATCAGCTCCTAATCCATTGAAAAATGAGAAAATCCCATGAGG tgtggaattgtgagcggata 
AM154ACACAAGACATATTCCTGGGCAGC 
AM167AACAAACCCACTCATCTCATCAAAA 
AM170CTGAGCTGGCTGAGCTGGTTATGGTAT 
AM173GGATACGATCGTGATAACTTCAACGACAGAGGTGGATCATACGATCGTGAAAGATCTCC AACCCGTTTTggtggtggttctaaaggtgaagaattatt 
AM199GGTCGCTTTATTTCCGTACCGAG 
AM203GACTACACTCCATTTATTAAAACTGCaATGGAAGAACCNcoI−
AM204GGTTCTTCCATtGCAGTTTTAATAAATGGAGTGTAGTCNcoI−
AM208CACAGGTTGCAGAAATTTGATACCC 
AM213GGTATAGAGATGCTGGTTGG 
AM214GTGGAACTGCACACTACTACTAG 
AM244GGATATGATAGAGGTGGATACGATCGTGATAACTTCAACGACAGAGGTGGATCATACG ATCGTGAAAGAgCTCCAACCCGTTTTggtggtggttctaaaggtgaagaattatt 
AM247CAAACTGTAATCTTTTTCTTAATTCCCTTTGGAAACACATCCTAAACGTACTTGATTCTTA GCTGATGTAGtctagaaggaccacctttgattg 
AM258CCAAAATTGGGACAACACC 
a
Lowercase indicates nucleotide differences from endogenous genes. Introduced or deleted restriction sites are underlined.
b
+, introduced restriction site; −, deleted restriction site.
TABLE 3.
TABLE 3. Plasmids used in this study
PlasmidFeaturesSource or reference
pAM91CEN LEU pNop-PrA-ScHMT1 AmprThis study
pAM160CEN LEU2 ScHMT1p-CaHMT1 AmprThis study
pAM161CEN LEU2 ScHMT1p-HsPRMT1 AmprThis study
pAM322CEN LEU2 CaHMT1 AmprThis study
pAM361CEN LEU pNop-PrA-CaNPL3 AmprThis study
pAM362CEN LEU pNop-PrA-ScNPL3-CaRGG AmprThis study
pAM385URA3 CaHMT1 AmprThis study
pAM390CEN URA3 CaHMT1 AmprThis study
pAM463CEN LEU pNop-PrA-ScNPL3-ApaI AmprThis study
pBSK-URAURA3 Ampr30
pDS10URA3 Ampr30
pGEMHIS1HIS1 Ampr45
pMG1602GFP URA3 Ampr19
pNOPPATACEN LEU pNop-PrA Ampr vector22
pPS1302GST-HsPRMT1v2 Ampr35
pPS1307CEN URA3 ScHMT1 Ampr24
pPS1872CEN LEU2 ScHMT1 Ampr27
pPS2389CEN LEU pNop-PrA-ScNPL3 Ampr49
pPS2575CEN URA3 ScHMT1antenna Ampr44
pRSARG4ΔSpeIARG4 Ampr45
pRS315CEN LEU2 Ampr vector39
pRS316CEN URA3 Ampr vector39

Acknowledgments

We thank P. Silver for S. cerevisiae plasmids, strains, and antibodies; M. Swanson for the 1E4 antibody; A. Mitchell for C. albicans strains and plasmids; D. Sheppard, S. Filler, and J. Berman for C. albicans plasmids; and R. Wheeler for C. albicans CAI-1 genomic DNA. We are grateful to Anita Corbett and Michael Yu for critical reading of the manuscript.
This work was supported in part by the following grants: National Science Foundation grant MCB-0235590 (to A.E.M.), Howard Hughes Medical Institute summer research fellowships (to E.B., A.C., and S.E.), a National Institutes of Health IDeA Network of Biomedical Research Excellence Program of the National Center for Research Resources summer research fellowship (to A.R.), and National Institutes of Health grant GM026020 (to S.C.).

REFERENCES

1.
Arnaud, M., M. Costanzo, M. Skrzypek, G. Binkley, C. Lane, S. Miyasato, and G. Sherlock. 2007, posting date. Candida genome database.http://www.candidagenome.org/ . Accessed 9 March 2007.
2.
Arnaud, M. B., M. C. Costanzo, M. S. Skrzypek, G. Binkley, C. Lane, S. R. Miyasato, and G. Sherlock. 2005. The Candida genome database (CGD), a community resource for Candida albicans gene and protein information. Nucleic Acids Res.33:D358-D363.
3.
Bachand, F., and P. A. Silver. 2004. PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits. EMBO J.23:2641-2650.
4.
Bedford, M. T., A. Frankel, M. B. Yaffe, S. Clarke, P. Leder, and S. Richard. 2000. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J. Biol. Chem.275:16030-16036.
5.
Bedford, M. T., and S. Richard. 2005. Arginine methylation an emerging regulator of protein function. Mol. Cell18:263-272.
6.
Boisvert, F. M., C. A. Chenard, and S. Richard. 2005. Protein interfaces in signaling regulated by arginine methylation. Sci. STKE2005:re2.
7.
Bossie, M. A., C. DeHoratius, G. Barcelo, and P. Silver. 1992. A mutant nuclear protein with similarity to RNA binding proteins interferes with nuclear import in yeast. Mol. Biol. Cell3:875-893.
8.
Branscombe, T. L., A. Frankel, J. H. Lee, J. R. Cook, Z. Yang, S. Pestka, and S. Clarke. 2001. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J. Biol. Chem.276:32971-32976.
9.
Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins, and J. D. Thompson. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res.31:3497-3500.
10.
Chern, M. K., K. N. Chang, L. F. Liu, T. C. Tam, Y. C. Liu, Y. L. Liang, and M. F. Tam. 2002. Yeast ribosomal protein L12 is a substrate of protein-arginine methyltransferase 2. J. Biol. Chem.277:15345-15353.
11.
Cook, J. R., J. H. Lee, Z. H. Yang, C. D. Krause, N. Herth, R. Hoffmann, and S. Pestka. 2006. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem. Biophys. Res. Commun.342:472-481.
12.
Cote, J., F. M. Boisvert, M. C. Boulanger, M. T. Bedford, and S. Richard. 2003. Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol. Biol. Cell14:274-287.
13.
Dietrich, F. S., S. Voegeli, S. Brachat, A. Lerch, K. Gates, S. Steiner, C. Mohr, R. Pohlmann, P. Luedi, S. Choi, R. A. Wing, A. Flavier, T. D. Gaffney, and P. Philippsen. 2004. The Ashbya gossypii genome as a tool for mapping the ancient Saccharomyces cerevisiae genome. Science304:304-307.
14.
Dujon, B., D. Sherman, G. Fischer, P. Durrens, S. Casaregola, I. Lafontaine, J. De Montigny, C. Marck, C. Neuveglise, E. Talla, N. Goffard, L. Frangeul, M. Aigle, V. Anthouard, A. Babour, V. Barbe, S. Barnay, S. Blanchin, J. M. Beckerich, E. Beyne, C. Bleykasten, A. Boisrame, J. Boyer, L. Cattolico, F. Confanioleri, A. De Daruvar, L. Despons, E. Fabre, C. Fairhead, H. Ferry-Dumazet, A. Groppi, F. Hantraye, C. Hennequin, N. Jauniaux, P. Joyet, R. Kachouri, A. Kerrest, R. Koszul, M. Lemaire, I. Lesur, L. Ma, H. Muller, J. M. Nicaud, M. Nikolski, S. Oztas, O. Ozier-Kalogeropoulos, S. Pellenz, S. Potier, G. F. Richard, M. L. Straub, A. Suleau, D. Swennen, F. Tekaia, M. Wesolowski-Louvel, E. Westhof, B. Wirth, M. Zeniou-Meyer, I. Zivanovic, M. Bolotin-Fukuhara, A. Thierry, C. Bouchier, B. Caudron, C. Scarpelli, C. Gaillardin, J. Weissenbach, P. Wincker, and J. L. Souciet. 2004. Genome evolution in yeasts. Nature430:35-44.
15.
Fischer, G., E. P. Rocha, F. Brunet, M. Vergassola, and B. Dujon. 2006. Highly variable rates of genome rearrangements between hemiascomycetous yeast lineages. PLoS Genet.2:e32.
16.
Flach, J., M. Bossie, J. Vogel, A. Corbett, T. Jinks, D. A. Willins, and P. A. Silver. 1994. A yeast RNA-binding protein shuttles between the nucleus and the cytoplasm. Mol. Cell. Biol.14:8399-8407.
17.
Frankel, A., and S. Clarke. 2000. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain. J. Biol. Chem.275:32974-32982.
18.
Gary, J. D., W. J. Lin, M. C. Yang, H. R. Herschman, and S. Clarke. 1996. The predominant protein-arginine methyltransferase from Saccharomyces cerevisiae. J. Biol. Chem.271:12585-12594.
19.
Gerami-Nejad, M., J. Berman, and C. A. Gale. 2001. Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans. Yeast18:859-864.
20.
Gilbert, W., C. W. Siebel, and C. Guthrie. 2001. Phosphorylation by Sky1p promotes Npl3p shuttling and mRNA dissociation. RNA7:302-313.
21.
Green, D. M., K. A. Marfatia, E. B. Crafton, X. Zhang, X. Cheng, and A. H. Corbett. 2002. Nab2p is required for poly(A) RNA export in Saccharomyces cerevisiae and is regulated by arginine methylation via Hmt1p. J. Biol. Chem.277:7752-7760.
22.
Hellmuth, K., D. M. Lau, F. R. Bischoff, M. Kunzler, E. Hurt, and G. Simos. 1998. Yeast Los1p has properties of an exportin-like nucleocytoplasmic transport factor for tRNA. Mol. Cell. Biol.18:6374-6386.
23.
Henry, M., C. Z. Borland, M. Bossie, and P. A. Silver. 1996. Potential RNA binding proteins in Saccharomyces cerevisiae identified as suppressors of temperature-sensitive mutations in NPL3. Genetics142:103-115.
24.
Henry, M. F., and P. A. Silver. 1996. A novel methyltransferase (Hmt1p) modifies poly(A)+-RNA-binding proteins. Mol. Cell. Biol.16:3668-3678.
25.
Lee, M. S., M. Henry, and P. A. Silver. 1996. A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export. Genes Dev.10:1233-1246.
26.
McBride, A. E., J. T. Cook, E. A. Stemmler, K. L. Rutledge, K. A. McGrath, and J. A. Rubens. 2005. Arginine methylation of yeast mRNA-binding protein Npl3 directly affects its function, nuclear export, and intranuclear protein interactions. J. Biol. Chem.280:30888-30898.
27.
McBride, A. E., V. H. Weiss, H. K. Kim, J. M. Hogle, and P. A. Silver. 2000. Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. J. Biol. Chem.275:3128-3136.
28.
Miranda, T. B., J. Sayegh, A. Frankel, J. E. Katz, M. Miranda, and S. Clarke. 2006. Yeast Hsl7 (histone synthetic lethal 7) catalyses the in vitro formation of omega-N(G)-monomethylarginine in calf thymus histone H2A. Biochem. J.395:563-570.
29.
Niewmierzycka, A., and S. Clarke. 1999. S-Adenosylmethionine-dependent methylation in Saccharomyces cerevisiae. Identification of a novel protein arginine methyltransferase. J. Biol. Chem.274:814-824.
30.
Park, H., C. L. Myers, D. C. Sheppard, Q. T. Phan, A. A. Sanchez, E. E. J., and S. G. Filler. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol.7:499-510.
31.
Perreault, A., C. Lemieux, and F. Bachand. 2007. Regulation of the nuclear poly(A) binding protein by arginine methylation in fission yeast. J. Biol. Chem.282:7552-7562.
32.
Pollack, B. P., S. V. Kotenko, W. He, L. S. Izotova, B. L. Barnoski, and S. Pestka. 1999. The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J. Biol. Chem.274:31531-31542.
33.
Porras-Yakushi, T. R., J. P. Whitelegge, T. B. Miranda, and S. Clarke. 2005. A novel SET domain methyltransferase modifies ribosomal protein Rpl23ab in yeast. J. Biol. Chem.280:34590-34598.
34.
Rose, M. D., F. Winston, and P. Hieter. 1990. Methods in yeast genetics: a laboratory course manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35.
Scott, H. S., S. E. Antonarakis, M. D. Lalioti, C. Rossier, P. A. Silver, and M. F. Henry. 1998. Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2). Genomics48:330-340.
36.
Senger, B., G. Simos, F. R. Bischoff, A. Podtelejnikov, M. Mann, and E. Hurt. 1998. Mtr10p functions as a nuclear import receptor for the mRNA-binding protein Npl3p. EMBO J.17:2196-2207.
37.
Shen, E. C., M. F. Henry, V. H. Weiss, S. R. Valentini, P. A. Silver, and M. S. Lee. 1998. Arginine methylation facilitates the nuclear export of hnRNP proteins. Genes Dev.12:679-691.
38.
Siebel, C. W., and C. Guthrie. 1996. The essential yeast RNA binding protein Np13p is methylated. Proc. Natl. Acad. Sci. USA93:13641-13646.
39.
Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics122:19-27.
40.
Smith, W. A., B. T. Schurter, F. Wong-Staal, and M. David. 2004. Arginine methylation of RNA helicase A determines its subcellular localization. J. Biol. Chem.279:22795-22798.
41.
Tang, J., A. Frankel, R. J. Cook, S. Kim, W. K. Paik, K. R. Williams, S. Clarke, and H. R. Herschman. 2000. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J. Biol. Chem.275:7723-7730.
42.
Theesfeld, C. L., T. R. Zyla, E. G. Bardes, and D. J. Lew. 2003. A monitor for bud emergence in the yeast morphogenesis checkpoint. Mol. Biol. Cell14:3280-3291.
43.
Umeyama, T., A. Kaneko, Y. Nagai, N. Hanaoka, K. Tanabe, Y. Takano, M. Niimi, and Y. Uehara. 2005. Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence. Mol. Microbiol.55:381-395.
44.
Weiss, V. H., A. E. McBride, M. A. Soriano, D. J. Filman, P. A. Silver, and J. M. Hogle. 2000. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1. Nat. Struct. Biol.7:1165-1171.
45.
Wilson, R. B., D. Davis, and A. P. Mitchell. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol.181:1868-1874.
46.
Wilson, S. M., K. V. Datar, M. R. Paddy, J. R. Swedlow, and M. S. Swanson. 1994. Characterization of nuclear polyadenylated RNA-binding proteins in Saccharomyces cerevisiae. J. Cell Biol.127:1173-1184.
47.
Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis.39:309-317.
48.
Wood, V., R. Gwilliam, M. A. Rajandream, M. Lyne, R. Lyne, A. Stewart, J. Sgouros, N. Peat, J. Hayles, S. Baker, D. Basham, S. Bowman, K. Brooks, D. Brown, S. Brown, T. Chillingworth, C. Churcher, M. Collins, R. Connor, A. Cronin, P. Davis, T. Feltwell, A. Fraser, S. Gentles, A. Goble, N. Hamlin, D. Harris, J. Hidalgo, G. Hodgson, S. Holroyd, T. Hornsby, S. Howarth, E. J. Huckle, S. Hunt, K. Jagels, K. James, L. Jones, M. Jones, S. Leather, S. McDonald, J. McLean, P. Mooney, S. Moule, K. Mungall, L. Murphy, D. Niblett, C. Odell, K. Oliver, S. O'Neil, D. Pearson, M. A. Quail, E. Rabbinowitsch, K. Rutherford, S. Rutter, D. Saunders, K. Seeger, S. Sharp, J. Skelton, M. Simmonds, R. Squares, S. Squares, K. Stevens, K. Taylor, R. G. Taylor, A. Tivey, S. Walsh, T. Warren, S. Whitehead, J. Woodward, G. Volckaert, R. Aert, J. Robben, B. Grymonprez, I. Weltjens, E. Vanstreels, M. Rieger, M. Schafer, S. Muller-Auer, C. Gabel, M. Fuchs, A. Dusterhoft, C. Fritzc, E. Holzer, D. Moestl, H. Hilbert, K. Borzym, I. Langer, A. Beck, H. Lehrach, R. Reinhardt, T. M. Pohl, P. Eger, W. Zimmermann, H. Wedler, R. Wambutt, B. Purnelle, A. Goffeau, E. Cadieu, S. Dreano, S. Gloux, et al. 2002. The genome sequence of Schizosaccharomyces pombe. Nature415:871-880.
49.
Yu, M. C., F. Bachand, A. E. McBride, S. Komili, J. M. Casolari, and P. A. Silver. 2004. Arginine methyltransferase affects interactions and recruitment of mRNA processing and export factors. Genes Dev.18:2024-2035.
50.
Yun, C. Y., and X. D. Fu. 2000. Conserved SR protein kinase functions in nuclear import and its action is counteracted by arginine methylation in Saccharomyces cerevisiae. J. Cell Biol.150:707-718.
51.
Zhang, X., and X. Cheng. 2003. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure11:509-520.

Information & Contributors

Information

Published In

cover image Eukaryotic Cell
Eukaryotic Cell
Volume 6Number 7July 2007
Pages: 1119 - 1129
PubMed: 17483287

History

Received: 9 March 2007
Accepted: 30 April 2007
Published online: 1 July 2007

Permissions

Request permissions for this article.

Contributors

Authors

Anne E. McBride [email protected]
Department of Biology, Bowdoin College, Brunswick, Maine 04011
Cecilia Zurita-Lopez
Department of Chemistry and Biochemistry, UCLA, Los Angeles, California 90095
Anthony Regis
Department of Biology, Bowdoin College, Brunswick, Maine 04011
Emily Blum
Department of Biology, Bowdoin College, Brunswick, Maine 04011
Ana Conboy
Department of Biology, Bowdoin College, Brunswick, Maine 04011
Shannon Elf
Department of Biology, Bowdoin College, Brunswick, Maine 04011
Steven Clarke
Department of Chemistry and Biochemistry, UCLA, Los Angeles, California 90095

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy